Actively Recruiting
MicroRNA as Markers in Testicular Cancer
Led by Haukeland University Hospital · Updated on 2022-08-08
350
Participants Needed
6
Research Sites
521 weeks
Total Duration
On this page
Sponsors
H
Haukeland University Hospital
Lead Sponsor
K
Karolinska University Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The main objective of this study is establish the performance of miR371 in management of testicular cancer
CONDITIONS
Official Title
MicroRNA as Markers in Testicular Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with suspected testicular cancer, referred to orchiectomy.
- Patients diagnosed with testicular germ cell cancer.
- Age 18-70 years.
- Must be able to receive information and give consent.
You will not qualify if you...
- Other prior or current cancers besides testicular cancer.
- Diseases or conditions that prevent receiving information or participating in follow-up.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
Haukeland University Hospital
Bergen, Norway, 5021
Actively Recruiting
2
Haugesund Hospital
Haugesund, Norway, 5528
Actively Recruiting
3
Oslo University Hospital
Oslo, Norway, 0379
Not Yet Recruiting
4
University Hospital of North Norway
Tromsø, Norway, 9038
Actively Recruiting
5
Sahlgrenska University Hospital
Gothenburg, Sweden, 41345
Not Yet Recruiting
6
Karolinska University Hospital
Stockholm, Sweden
Actively Recruiting
Research Team
M
Mette Pernille Myklebust, PhD
CONTACT
O
Olav Dahl, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here